NAS
CKPT

NWF Advisory Services’s Checkpoint Therapeutics CKPT Stock Holding History

NWF Advisory Services’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,900
Closed -$24.4K – 308
2024
Q3 		$24.4K Buy
10,900
+370
+4% +$854 ﹤0.01% 338
2024
Q2 		$22.6K Buy
+10,530
New +$18.7K ﹤0.01% 318

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

NWF Advisory Services's CKPT Position: Q4 2024 in Review

NWF Advisory Services sold out of Checkpoint Therapeutics (CKPT) in Q4 2024, closing a stake of 10,900 shares — an estimated $24.4K sold.

NWF Advisory Services first reported a position in CKPT in Q2 2024 and held it in 2 quarters. The position peaked at $24.4K in Q3 2024. 68 funds tracked by Wall St. Rank hold CKPT as of Q4 2024.

  • NWF Advisory Services reported no remaining Checkpoint Therapeutics position as of Q4 2024 after selling out during the quarter.
  • NWF Advisory Services sold 10,900 Checkpoint Therapeutics shares in Q4 2024, an estimated $24.4K.
  • NWF Advisory Services first reported a position in Checkpoint Therapeutics in Q2 2024 and held it in 2 quarters.
  • NWF Advisory Services's Checkpoint Therapeutics position peaked at $24.4K in Q3 2024.
  • 68 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2024.

Based on NWF Advisory Services's 13F filing for Q4 2024, filed 14 May 2025.